The differential effect of risperidone and olanzapine on insulin sensitivity after 3 weeks of treatment: a HOMA pilot study

Background and Methods: Patients with an acute psychotic episode underwent HOMA testing for insulin sensitivity (IS) prior to and after 3 weeks of treatment with olanzapine (n=7) or risperidone (n=7). Results and Discussion: The HOMA-IS index was reduced in the olanzapine group, but significantly in...

Full description

Saved in:
Bibliographic Details
Main Authors: Paslakis, Georgios (Author) , Deuschle, Michael (Author)
Format: Article (Journal)
Language:English
Published: 2012
In: Pharmacopsychiatry
Year: 2012, Volume: 45, Issue: 03, Pages: 96-99
ISSN:1439-0795
DOI:10.1055/s-0031-1297935
Online Access:Verlag, Volltext: http://dx.doi.org/10.1055/s-0031-1297935
Verlag, Volltext: http://www.thieme-connect.de.ezproxy.medma.uni-heidelberg.de/DOI/DOI?10.1055/s-0031-1297935
Get full text
Author Notes:G. Paslakis, M. Deuschle, J. Thome, S. Rüße, D. Kopf
Description
Summary:Background and Methods: Patients with an acute psychotic episode underwent HOMA testing for insulin sensitivity (IS) prior to and after 3 weeks of treatment with olanzapine (n=7) or risperidone (n=7). Results and Discussion: The HOMA-IS index was reduced in the olanzapine group, but significantly increased in patients treated with risperidone. There was a significant “time x medication” interaction (p=0.03). The BMI significantly increased as a result of both treatments. IS can be acutely ameliorated by antipsychotic treatment with risperidone despite weight increase. Conclusions: Compared to risperidone, the IS is impaired after a 3-week treatment with olanzapine. Already short-term antipsychotic treatment may have effects on insulin sensitivity.
Item Description:Gesehen am 30.04.2018
Physical Description:Online Resource
ISSN:1439-0795
DOI:10.1055/s-0031-1297935